Skip to main content
. 2017 Apr 7;21:16-102. doi: 10.7812/TPP/16-102

Table 3.

Current disease-modifying agent (DMA) received by respondents

Medication Number (%)
Interferon beta-1a 67 (12.5)
Interferon beta-1b 20 (3.7)
Glatiramer acetate 105 (19.6)
Fingolimod hydrochloride 15 (2.8)
Teriflunomide 15 (2.8)
Dimethyl fumarate 44 (8.2)
Natalizumab 13 (2.4)
Not currently receiving DMA 258 (48.0)